Interest in branded programs wanes

Share this article:
Interest in attending sponsored speaker programs in a traditional dinner program format is waning, says medical meetings producer Pri-Med. Across 37 Pri-Med events in 2010, nearly 8,000 physicians opted into at least one pharma-sponsored promotional speaker program, the firm said. A 2009 survey completed by physicians as they were leaving branded programs at 12 meetings suggested higher numbers.
Who's the typical clinician sitting in on these events? According to a 2010 study of 2,238 speaker program attendees, there were only slight demographic differences between those clinicians who opted into sponsored speaker programs and those who did not.
Program attendees skewed slightly more toward hospital-based or hospital-owned practices. In addition, many were active and “high value” to industry (read: high-prescribing).
It's well known that more office practices are putting up barriers to sales reps. Nearly one in three physicians is hard to reach, Pri-Med says, meaning they are either heavily restrictive or don't see reps at all.
Away from their practices, though, it's a different story. Pri-Med found that physicians who are most restrictive regarding while in practice, often do opt in to branded speaker programs when already at an event where these promotional programs are available: three-quarters of “restricted” physicians and 58% of “no-see” physicians attended at least one promotional program.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.